Publikationen, an denen er mitarbeitet Patrice Le Pape (9)

2023

  1. The Mortality Attributable to Candidemia in C. auris Is Higher than That in Other Candida Species: Myth or Reality?

    Journal of Fungi, Vol. 9, Núm. 4

2022

  1. CRISPR-Cas9 approach confirms Calcineurinresponsive zinc finger 1 (Crz1) transcription factor as a promising therapeutic target in echinocandin-resistant Candida glabrata

    PLoS ONE, Vol. 17, Núm. 3 March

  2. Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 3, pp. 585-597

  3. Head‐to‐head comparison of CLSI, EUCAST, Etest and VITEK®2 results for Candida auris susceptibility testing

    International Journal of Antimicrobial Agents, Vol. 59, Núm. 4

2020

  1. Impact of calmodulin inhibition by fluphenazine on susceptibility, biofilm formation and pathogenicity of caspofungin-resistant Candida glabrata

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 5, pp. 1187-1193

  2. Palindromic Peptide LfcinB (21-25)Pal Exhibited Antifungal Activity against Multidrug-Resistant Candida

    ChemistrySelect, Vol. 5, Núm. 24, pp. 7236-7242

  3. Persistence of clonal azole-resistant isolates of Candida albicans from a patient with chronic mucocutaneous candidiasis in Colombia

    Journal of Global Infectious Diseases, Vol. 12, Núm. 1, pp. 16-20

2019

  1. Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia

    BMC Microbiology, Vol. 19, Núm. 1

2018

  1. First report of sporadic cases of Candida auris in Colombia

    International Journal of Infectious Diseases, Vol. 69, pp. 63-67